Bellicum Pharmaceuticals, Inc. ( NASDAQ:BLCM – Get Rating ) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,440,000 shares, a growth of 173.1% from the April 30th total of 527,200 shares. Based on an average trading volume of 2,870,000 shares, the short-interest ratio is presently 0.5 days. Analyst Ratings Changes A number of research firms have recently commented on BLCM. StockNews.com began coverage on shares of Bellicum Pharmaceuticals in a report on Wednesday.

https://www.dailypolitical.com/2023/05/27/bellicum-pharmaceuticals-inc-nasdaqblcm-short-interest-update.html

#dailypolitical